Condition reference
Microchip identificationMicrochip implantation site selection
Explore the linked guideline and related drug references. A matching drug entry does not establish a treatment recommendation.
WSAVA guideline
WSAVA Microchip Identification Guidelines
WSAVA's core message is that "standardization of microchip implantation sites is essential to the overall integrity of a radio frequency identification (RFID) system" — especially for FDX-based protocols, whose effective reader–transponder interrogation distance is short, so a scanner must be held where the chip is expected. For dogs and cats two recognised sites are in simultaneous use: subcutaneously on the dorsal midline just cranial to the shoulder blades (standard in all countries *except* those of Europe — explicitly including the UK and Republic of Ireland) and subcutaneously in the midway region of the left neck (continental Europe, excluding UK/Ireland). Until a single global site is agreed, scanning concentrates on the local site and — if negative — the alternative site must also be scanned. Migration is not discussed as an adverse event in the source; the closest content is the recommendation to scan implanted animals annually "to ensure proper function and location."
WSAVA Microchip Identification Guidelines (wsava.org web guideline; Microchip Subcommittee; no publication year stated in source)
Key findings
- Why consistency matters: site standardisation is "essential to the overall integrity of a… (RFID) system," most critical for FDX protocols because their effective interrogation distance is relatively short — readers only find chips where operators know to look ("Guidelines").
- Standard site 1 (non-European countries): subcutaneously on the dorsal midline just cranial to the shoulder blades (scapula) — "the standard implantation site in all countries… excluding those of Europe," explicitly including the UK (Wales, Scotland, England, Northern Ireland) and the Republic of Ireland ("Canine and Feline").
- Standard site 2 (continental Europe): subcutaneously in the midway region of the left neck — "the standard implantation site in continental Europe," excluding the UK and Republic of Ireland ("Canine and Feline").
- Scan-both-sites rule: until one common global site is agreed, scanning must concentrate on the site used locally, and "should an animal scan negative, it is strongly recommended that the alternative site… also be scanned" ("Canine and Feline").
- Reader as system component: a functional reader is "an integral, and often overlooked, component" of the RFID system — "without this, the system fails" ("Enhancing Reader Performance").
- ISO backbone: global protocol standardisation came via ISO 11784 and 11785 (bit content + communication protocol), whose adoption strengthened marketplace confidence and enabled widespread implementation ("Guidelines").
- Asepsis and analgesia: aseptic technique "as with any injection" is recommended; local anaesthetic use is "up to the individual veterinarian to assess" ("Guidelines").
- Migration: not addressed as a complication anywhere in the source; the annual rescan "to ensure proper function and location" is the only location-surveillance content [verify against current WSAVA page].
Recommendations
Use standardised implantation sites per species/locale to preserve RFID system integrity (reader–transponder proximity, critical for FDX)
"essential to the overall integrity of a… (RFID) system"
Dogs/cats outside Europe (incl. UK, Republic of Ireland): dorsal midline just cranial to shoulder blades, subcutaneous
"the standard implantation site in all countries… excluding those of Europe"
Dogs/cats in continental Europe (excl. UK/Ireland): midway region of the left neck, subcutaneous
"the standard implantation site in continental Europe"
Concentrate scanning on the local site; if negative, also scan the alternative site until one global site is agreed
alternative-site scan "strongly recommended"
Scan all recognised implantation sites when searching for a chip
"all recognized implantation sites should be scanned"
Aseptic technique for every implantation; local anaesthetic at clinician's discretion
"recommended" / "up to the individual veterinarian"
Scan every implanted animal annually to confirm chip function and location (the source's only migration-related safeguard)
"should be scanned annually"
Related drugs in this reference (0)
No indication text currently matches this condition by name. Try a broader condition or search the drug reference directly. Absence of a match does not establish that treatment is unavailable.
Built from summaries/09-microchip.md vs the full page text. No publication year in source (ISO history only: 1996 first edition, Annex A ended 1998). Migration, adverse reactions and chip-failure rates are not discussed — gaps in the guideline itself [verify against current page]. Non-companion species: T24; reader workflow: T26.